Acadia Healthcare (NASDAQ:ACHC – Get Free Report) and P3 Health Partners (NASDAQ:PIII – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.
Insider & Institutional Ownership
7.7% of P3 Health Partners shares are held by institutional investors. 1.2% of Acadia Healthcare shares are held by company insiders. Comparatively, 10.9% of P3 Health Partners shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Acadia Healthcare and P3 Health Partners”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Acadia Healthcare | $3.31 billion | 0.79 | -$1.10 billion | ($12.45) | -2.25 |
| P3 Health Partners | $1.46 billion | 0.04 | -$147.95 million | ($33.00) | -0.25 |
P3 Health Partners has lower revenue, but higher earnings than Acadia Healthcare. Acadia Healthcare is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Acadia Healthcare and P3 Health Partners’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Acadia Healthcare | -33.44% | 6.19% | 2.42% |
| P3 Health Partners | -6.55% | N/A | -16.40% |
Risk & Volatility
Acadia Healthcare has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 1.63, suggesting that its stock price is 63% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current recommendations for Acadia Healthcare and P3 Health Partners, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Acadia Healthcare | 2 | 5 | 7 | 1 | 2.47 |
| P3 Health Partners | 1 | 2 | 1 | 0 | 2.00 |
Acadia Healthcare presently has a consensus price target of $29.85, suggesting a potential upside of 6.59%. P3 Health Partners has a consensus price target of $17.00, suggesting a potential upside of 107.06%. Given P3 Health Partners’ higher possible upside, analysts clearly believe P3 Health Partners is more favorable than Acadia Healthcare.
Summary
Acadia Healthcare beats P3 Health Partners on 8 of the 15 factors compared between the two stocks.
About Acadia Healthcare
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
About P3 Health Partners
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
